{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:44:15Z","timestamp":1793659455844,"version":"4.5.1"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/nrneph.2015.8","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T09:07:21Z","timestamp":1423559241000},"page":"161-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":328,"title":["Sickle cell disease: renal manifestations and mechanisms"],"prefix":"10.1038","volume":"11","author":[{"given":"Karl A.","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hebbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,10]]},"reference":[{"key":"BFnrneph20158_CR1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archinte.1974.00320160154014","volume":"133","author":"VM Buckalew Jr","year":"1974","unstructured":"Buckalew, V. M. Jr & Someren, A. Renal manifestations of sickle cell disease. Arch. Intern. Med. 133, 660\u2013669 (1974).","journal-title":"Arch. Intern. Med."},{"key":"BFnrneph20158_CR2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ki.1975.54","volume":"7","author":"GA Alleyne","year":"1975","unstructured":"Alleyne, G. A. The kidney in sickle cell anemia. Kidney Int. 7, 371\u2013379 (1975).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ki.1985.70","volume":"27","author":"PE de Jong","year":"1985","unstructured":"de Jong, P. E. & Statius van Eps, L. W. Sickle cell nephropathy: new insights into its pathophysiology. Kidney Int. 27, 711\u2013717 (1985).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archinte.1990.00390150015003","volume":"150","author":"M Allon","year":"1990","unstructured":"Allon, M. Renal abnormalities in sickle cell disease. Arch. Intern. Med. 150, 501\u2013504 (1990).","journal-title":"Arch. Intern. Med."},{"key":"BFnrneph20158_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1755.2000.00806.x","volume":"57","author":"PT Pham","year":"2000","unstructured":"Pham, P. T., Pham, P. C., Wilkinson, A. H. & Lew, S. Q. Renal abnormalities in sickle cell disease. Kidney Int. 57, 1\u20138 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.0.CO;2-8","volume":"63","author":"KI Ataga","year":"2000","unstructured":"Ataga, K. I. & Orringer, E. P. Renal abnormalities in sickle cell disease. Am. J. Hematol. 63, 205\u2013211 (2000).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR7","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1046\/j.1523-1755.2002.00363.x","volume":"61","author":"DE Wesson","year":"2002","unstructured":"Wesson, D. E. The initiation and progression of sickle cell nephropathy. Kidney Int. 61, 2277\u20132286 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10739680490278592","volume":"11","author":"KA Nath","year":"2004","unstructured":"Nath, K. A., Katusic, Z. S. & Gladwin, M. T. The perfusion paradox and vascular instability in sickle cell disease. Microcirculation 11, 179\u2013193 (2004).","journal-title":"Microcirculation"},{"key":"BFnrneph20158_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ncpneph1008","volume":"5","author":"JI Scheinman","year":"2009","unstructured":"Scheinman, J. I. Sickle cell disease and the kidney. Nat. Clin. Pract. Nephrol. 5, 78\u201388 (2009).","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"BFnrneph20158_CR10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00277-011-1327-8","volume":"90","author":"GB da Silva Jr","year":"2011","unstructured":"da Silva, G. B. Jr, Lib\u00f3rio, A. B. & Daher Ede, F. New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy. Ann. Hematol. 90, 1371\u20131379 (2011).","journal-title":"Ann. Hematol."},{"key":"BFnrneph20158_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2141.2011.08853.x","volume":"155","author":"CC Sharpe","year":"2011","unstructured":"Sharpe, C. C. & Thein, S. L. Sickle cell nephropathy\u2014a practical approach. Br. J. Haematol. 155, 287\u2013297 (2011).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph20158_CR12","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00467-010-1736-2","volume":"26","author":"AM Becker","year":"2011","unstructured":"Becker, A. M. Sickle cell nephropathy: challenging the conventional wisdom. Pediatr. Nephrol. 26, 2099\u20132109 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph20158_CR13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1681\/ASN.2011101019","volume":"23","author":"KA Nath","year":"2012","unstructured":"Nath, K. A. & Katusic, Z. S. Vasculature and kidney complications in sickle cell disease. J. Am. Soc. Nephrol. 23, 781\u2013784 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR14","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2014-02-557439","volume":"123","author":"CC Sharpe","year":"2014","unstructured":"Sharpe, C. C. & Thein, S. L. How I treat renal complications in sickle cell disease. Blood 123, 3720\u20133726 (2014).","journal-title":"Blood"},{"key":"BFnrneph20158_CR15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ajh.23762","volume":"89","author":"KI Ataga","year":"2014","unstructured":"Ataga, K. I., Derebail, V. K. & Archer, D. R. The glomerulopathy of sickle cell disease. Am. J. Hematol. 89, 907\u2013914 (2014).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR16","doi-asserted-by":"crossref","first-page":"e79923","DOI":"10.1371\/journal.pone.0079923","volume":"8","author":"DS Darbari","year":"2013","unstructured":"Darbari, D. S. et al. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS ONE 8, e79923 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneph20158_CR17","doi-asserted-by":"crossref","first-page":"e99489","DOI":"10.1371\/journal.pone.0099489","volume":"9","author":"MT Gladwin","year":"2014","unstructured":"Gladwin, M. T. et al. Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PLoS ONE 9, e99489 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneph20158_CR18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajh.23683","volume":"89","author":"H Elmariah","year":"2014","unstructured":"Elmariah, H. et al. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am. J. Hematol. 89, 530\u2013535 (2014).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt, O. S. et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330, 1639\u20131644 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph20158_CR20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/pbc.24557","volume":"60","author":"D Hamideh","year":"2013","unstructured":"Hamideh, D. & Alvarez, O. Sickle cell disease related mortality in the United States (1999\u20132009). Pediatr. Blood Cancer 60, 1482\u20131486 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrneph20158_CR21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.12024","volume":"159","author":"AC McClellan","year":"2012","unstructured":"McClellan, A. C. et al. High one year mortality in adults with sickle cell disease and end-stage renal disease. Br. J. Haematol. 159, 360\u2013367 (2012).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph20158_CR22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","volume":"381","author":"FB Piel","year":"2013","unstructured":"Piel, F. B. et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381, 142\u2013151 (2013).","journal-title":"Lancet"},{"key":"BFnrneph20158_CR23","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel, F. B., Hay, S. I., Gupta, S., Weatherall, D. J. & Williams, T. N. Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 10, e1001484 (2013).","journal-title":"PLoS Med."},{"key":"BFnrneph20158_CR24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood.V77.2.214.214","volume":"77","author":"RP Hebbel","year":"1991","unstructured":"Hebbel, R. P. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 77, 214\u2013237 (1991).","journal-title":"Blood"},{"key":"BFnrneph20158_CR25","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1172\/JCI119442","volume":"99","author":"RP Hebbel","year":"1997","unstructured":"Hebbel, R. P. Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium. J. Clin. Invest. 99, 2561\u20132564 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph20158_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.hoc.2013.11.005","volume":"28","author":"RP Hebbel","year":"2014","unstructured":"Hebbel, R. P. Ischemia\u2013reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain. Hematol. Oncol. Clin. North Am. 28, 181\u2013198 (2014).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"BFnrneph20158_CR27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/WNL.39.3.344","volume":"39","author":"I Prohovnik","year":"1989","unstructured":"Prohovnik, I. et al. Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology 39, 344\u2013348 (1989).","journal-title":"Neurology"},{"key":"BFnrneph20158_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(55)90239-4","volume":"18","author":"JN Etteldorf","year":"1955","unstructured":"Etteldorf, J. N., Smith, J. D., Tuttle, A. H. & Diggs, L. W. Renal hemodynamic studies in adults with sickle cell anemia. Am. J. Med. 18, 243\u2013248 (1955).","journal-title":"Am. J. Med."},{"key":"BFnrneph20158_CR29","first-page":"632","volume":"76","author":"FE Hatch Jr","year":"1970","unstructured":"Hatch, F. E. Jr, Azar, S. H., Ainsworth, T. E., Nardo, J. M. & Culbertson, J. W. Renal circulatory studies in young adults with sickle cell anemia. J. Lab. Clin. Med. 76, 632\u2013640 (1970).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrneph20158_CR30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2009.06.060","volume":"156","author":"RE Ware","year":"2010","unstructured":"Ware, R. E. et al. Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. J. Pediatr. 156, 66\u201370.e1 (2010).","journal-title":"J. Pediatr."},{"key":"BFnrneph20158_CR31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ki.1996.301","volume":"50","author":"N Bank","year":"1996","unstructured":"Bank, N. et al. Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int. 50, 184\u2013189 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/snep.2003.50017","volume":"23","author":"TH Hostetter","year":"2003","unstructured":"Hostetter, T. H. Hyperfiltration and glomerulosclerosis. Semin. Nephrol. 23, 194\u2013199 (2003).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph20158_CR33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/ajkd.1998.v32.pm9708603","volume":"32","author":"F Schmitt","year":"1998","unstructured":"Schmitt, F. et al. Early glomerular dysfunction in patients with sickle cell anemia. Am. J. Kidney Dis. 32, 208\u2013214 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph20158_CR34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ki.1996.109","volume":"49","author":"A Guasch","year":"1996","unstructured":"Guasch, A., Cua, M. & Mitch, W. E. Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int. 49, 786\u2013791 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0009-8981(67)90222-7","volume":"17","author":"LW Statius van Eps","year":"1967","unstructured":"Statius van Eps, L. W., Schouten, H., La Porte-Wijsman, L. W. & Struyker Boudier, A. M. The influence of red blood cell transfusions on the hyposthenuria and renal hemodynamics of sickle cell anemia. Clin. Chim. Acta 17, 449\u2013461 (1967).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrneph20158_CR36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V2.2.192.192","volume":"2","author":"SE Bradley","year":"1947","unstructured":"Bradley, S. E. & Bradley, G. P. Renal function during chronic anemia in man. Blood 2, 192\u2013202 (1947).","journal-title":"Blood"},{"key":"BFnrneph20158_CR37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.mph.0000203722.91189.9d","volume":"28","author":"S Bergmann","year":"2006","unstructured":"Bergmann, S., Zheng, D., Barredo, J., Abboud, M. R. & Jaffa, A. A. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease. J. Pediatr. Hematol. Oncol. 28, 147\u2013153 (2006).","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"BFnrneph20158_CR38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9440(10)64037-0","volume":"158","author":"KA Nath","year":"2001","unstructured":"Nath, K. A. et al. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am. J. Pathol. 158, 893\u2013903 (2001).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph20158_CR39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2003-08-2760","volume":"104","author":"ML Jison","year":"2004","unstructured":"Jison, M. L. et al. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104, 270\u2013280 (2004).","journal-title":"Blood"},{"key":"BFnrneph20158_CR40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00000441-200112000-00007","volume":"322","author":"DA Sears","year":"2001","unstructured":"Sears, D. A., Udden, M. M. & Thomas, L. J. Carboxyhemoglobin levels in patients with sickle-cell anemia: relationship to hemolytic and vasoocclusive severity. Am. J. Med. Sci. 322, 345\u2013348 (2001).","journal-title":"Am. J. Med. Sci."},{"key":"BFnrneph20158_CR41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00431-004-1605-8","volume":"164","author":"KP Sylvester","year":"2005","unstructured":"Sylvester, K. P. et al. Exhaled carbon monoxide levels in children with sickle cell disease. Eur. J. Pediatr. 164, 162\u2013165 (2005).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrneph20158_CR42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.08511109","volume":"5","author":"JP Haymann","year":"2010","unstructured":"Haymann, J. P. et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin. J. Am. Soc. Nephrol. 5, 756\u2013761 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(70)90836-6","volume":"1","author":"LW Statius van Eps","year":"1970","unstructured":"Statius van Eps, L. W., Pinedo-Veels, C., de Vries, G. H. & de Koning, J. Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. Lancet 1, 450\u2013452 (1970).","journal-title":"Lancet"},{"key":"BFnrneph20158_CR44","first-page":"384","volume":"46","author":"TM Walker","year":"1996","unstructured":"Walker, T. M., Beardsall, K., Thomas, P. W. & Serjeant, G. R. Renal length in sickle cell disease: observations from a cohort study. Clin. Nephrol. 46, 384\u2013388 (1996).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph20158_CR45","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2214\/AJR.10.4664","volume":"196","author":"MB McCarville","year":"2011","unstructured":"McCarville, M. B. et al. Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial. AJR Am. J. Roentgenol. 196, 1399\u20131404 (2011).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrneph20158_CR46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ki.1986.45","volume":"29","author":"L Fine","year":"1986","unstructured":"Fine, L. The biology of renal hypertrophy. Kidney Int. 29, 619\u2013634 (1986).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev.ph.57.030195.001403","volume":"57","author":"TH Hostetter","year":"1995","unstructured":"Hostetter, T. H. Progression of renal disease and renal hypertrophy. Annu. Rev. Physiol. 57, 263\u2013278 (1995).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnrneph20158_CR48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","volume":"8","author":"I Helal","year":"2012","unstructured":"Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B. & Schrier, R. W. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nature Rev. Nephrol. 8, 293\u2013300 (2012).","journal-title":"Nature Rev. Nephrol."},{"key":"BFnrneph20158_CR49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOH.0b013e3282a4a673","volume":"14","author":"JE Brittain","year":"2007","unstructured":"Brittain, J. E. & Parise, L. V. Cytokines and plasma factors in sickle cell disease. Curr. Opin. Hematol. 14, 438\u2013443 (2007).","journal-title":"Curr. Opin. Hematol."},{"key":"BFnrneph20158_CR50","first-page":"403","volume":"90","author":"JA Pitcock","year":"1970","unstructured":"Pitcock, J. A., Muirhead, E. E., Hatch, F. E., Johnson, J. G. & Kelly, B. J. Early renal changes in sickle cell anemia. Arch. Pathol. 90, 403\u2013410 (1970).","journal-title":"Arch. Pathol."},{"key":"BFnrneph20158_CR51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.1971.03180160037009","volume":"215","author":"BR Walker","year":"1971","unstructured":"Walker, B. R., Alexander, F., Birdsall, T. R. & Warren, R. L. Glomerular lesions in sickle cell nephropathy. JAMA 215, 437\u2013440 (1971).","journal-title":"JAMA"},{"key":"BFnrneph20158_CR52","first-page":"357","volume":"77","author":"IB Elfenbein","year":"1974","unstructured":"Elfenbein, I. B., Patchefsky, A., Schwartz, W. & Weinstein, A. G. Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome. Am. J. Pathol. 77, 357\u2013374 (1974).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph20158_CR53","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000183404","volume":"39","author":"A Tejani","year":"1985","unstructured":"Tejani, A. et al. Renal lesions in sickle cell nephropathy in children. Nephron 39, 352\u2013355 (1985).","journal-title":"Nephron"},{"key":"BFnrneph20158_CR54","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1681\/ASN.V1111241","volume":"1","author":"DB Bhathena","year":"1991","unstructured":"Bhathena, D. B. & Sondheimer, J. H. The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis. J. Am. Soc. Nephrol. 1, 1241\u20131252 (1991).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR55","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199204023261402","volume":"326","author":"RJ Falk","year":"1992","unstructured":"Falk, R. J. et al. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N. Engl. J. Med. 326, 910\u2013915 (1992).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph20158_CR56","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.ki.5000234","volume":"69","author":"SH Nasr","year":"2006","unstructured":"Nasr, S. H., Markowitz, G. S., Sentman, R. L. & D'Agati, V. D. Sickle cell disease, nephrotic syndrome, and renal failure. Kidney Int. 69, 1276\u20131280 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MD.0b013e3181ca59b6","volume":"89","author":"G Maigne","year":"2010","unstructured":"Maigne, G. et al. Glomerular lesions in patients with sickle cell disease. Medicine (Baltimore) 89, 18\u201327 (2010).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph20158_CR58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s004670050491","volume":"12","author":"VR Dharnidharka","year":"1998","unstructured":"Dharnidharka, V. R., Dabbagh, S., Atiyeh, B., Simpson, P. & Sarnaik, S. Prevalence of microalbuminuria in children with sickle cell disease. Pediatr. Nephrol. 12, 475\u2013478 (1998).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph20158_CR59","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","volume":"17","author":"A Guasch","year":"2006","unstructured":"Guasch, A., Navarrete, J., Nass, K. & Zayas, C. F. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J. Am. Soc. Nephrol. 17, 2228\u20132235 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR60","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.JIM.0000446836.75352.72","volume":"62","author":"EO Gosmanova","year":"2014","unstructured":"Gosmanova, E. O., Zaidi, S., Wan, J. Y. & Adams-Graves, P. E. Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease. J. Investig. Med. 62, 804\u2013807 (2014).","journal-title":"J. Investig. Med."},{"key":"BFnrneph20158_CR61","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000167444","volume":"7","author":"AA Bakir","year":"1987","unstructured":"Bakir, A. A. et al. Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study. Am. J. Nephrol. 7, 110\u2013115 (1987).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph20158_CR62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","volume":"84","author":"DR Powars","year":"2005","unstructured":"Powars, D. R., Chan, L. S., Hiti, A., Ramicone, E. & Johnson, C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 84, 363\u2013376 (2005).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph20158_CR63","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pbc.24843","volume":"61","author":"AM Becker","year":"2014","unstructured":"Becker, A. M. et al. Blood pressure abnormalities in children with sickle cell anemia. Pediatr. Blood Cancer 61, 518\u2013522 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrneph20158_CR64","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archinte.167.7.701","volume":"167","author":"J Thompson","year":"2007","unstructured":"Thompson, J., Reid, M., Hambleton, I. & Serjeant, G. R. Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study. Arch. Intern. Med. 167, 701\u2013708 (2007).","journal-title":"Arch. Intern. Med."},{"key":"BFnrneph20158_CR65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.21016","volume":"83","author":"VR Gordeuk","year":"2008","unstructured":"Gordeuk, V. R. et al. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am. J. Hematol. 83, 15\u201318 (2008).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR66","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00467-011-1857-2","volume":"26","author":"B Aygun","year":"2011","unstructured":"Aygun, B., Mortier, N. A., Smeltzer, M. P., Hankins, J. S. & Ware, R. E. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr. Nephrol. 26, 1285\u20131290 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph20158_CR67","first-page":"209","volume":"87","author":"M Faulkner","year":"1995","unstructured":"Faulkner, M. et al. Severe anemia: a risk factor for glomerular injury in sickle cell disease. J. Natl Med. Assoc. 87, 209\u2013213 (1995).","journal-title":"J. Natl Med. Assoc."},{"key":"BFnrneph20158_CR68","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ajh.21994","volume":"86","author":"J Lebensburger","year":"2011","unstructured":"Lebensburger, J. et al. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia. Am. J. Hematol. 86, 430\u2013432 (2011).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR69","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00467-010-1560-8","volume":"25","author":"S Gurkan","year":"2010","unstructured":"Gurkan, S., Scarponi, K. J., Hotchkiss, H., Savage, B. & Drachtman, R. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr. Nephrol. 25, 2123\u20132127 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph20158_CR70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.2011.050336","volume":"97","author":"TG Day","year":"2012","unstructured":"Day, T. G., Drasar, E. R., Fulford, T., Sharpe, C. C. & Thein, S. L. Association between hemolysis and albuminuria in adults with sickle cell anemia. Haematologica 97, 201\u2013205 (2012).","journal-title":"Haematologica"},{"key":"BFnrneph20158_CR71","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00467-014-2821-8","volume":"29","author":"D Hamideh","year":"2014","unstructured":"Hamideh, D. et al. Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia. Pediatr. Nephrol. 29, 1997\u20132003 (2014).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph20158_CR72","first-page":"749","volume":"136","author":"DR Wigfall","year":"2000","unstructured":"Wigfall, D. R., Ware, R. E., Burchinal, M. R., Kinney, T. R. & Foreman, J. W. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J. Pediatr. 136, 749\u2013753 (2000).","journal-title":"J. Pediatr."},{"key":"BFnrneph20158_CR73","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","volume":"115","author":"DR Powars","year":"1991","unstructured":"Powars, D. R. et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann. Intern. Med. 115, 614\u2013620 (1991).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph20158_CR74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0609.2010.01471.x","volume":"85","author":"KI Ataga","year":"2010","unstructured":"Ataga, K. I. et al. Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1. Eur. J. Haematol. 85, 257\u2013263 (2010).","journal-title":"Eur. J. Haematol."},{"key":"BFnrneph20158_CR75","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ndt\/gft295","volume":"29","author":"LP Laurin","year":"2014","unstructured":"Laurin, L. P., Nachman, P. H., Desai, P. C., Ataga, K. I. & Derebail, V. K. Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease. Nephrol. Dial. Transplant. 29, 1211\u20131218 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph20158_CR76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(95)91324-6","volume":"346","author":"KJ Wierenga","year":"1995","unstructured":"Wierenga, K. J. et al. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet 346, 475\u2013476 (1995).","journal-title":"Lancet"},{"key":"BFnrneph20158_CR77","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","volume":"155","author":"AE Ashley-Koch","year":"2011","unstructured":"Ashley-Koch, A. E. et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br. J. Haematol. 155, 386\u2013394 (2011).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph20158_CR78","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V1051014","volume":"10","author":"A Guasch","year":"1999","unstructured":"Guasch, A. et al. Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J. Am. Soc. Nephrol. 10, 1014\u20131019 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR79","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.20800","volume":"82","author":"VG Nolan","year":"2007","unstructured":"Nolan, V. G. et al. Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B. Am. J. Hematol. 82, 179\u2013184 (2007).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR80","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ajh.22045","volume":"86","author":"N Sundaram","year":"2011","unstructured":"Sundaram, N. et al. Biomarkers for early detection of sickle nephropathy. Am. J. Hematol. 86, 559\u2013566 (2011).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR81","first-page":"CD009191","volume":"3","author":"TH Sasongko","year":"2013","unstructured":"Sasongko, T. H., Nagalla, S. & Ballas, S. K. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst. Rev. 3, CD009191 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrneph20158_CR82","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn, B. P. et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312, 1033\u20131048 (2014).","journal-title":"JAMA"},{"key":"BFnrneph20158_CR83","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/pbc.24100","volume":"59","author":"O Alvarez","year":"2012","unstructured":"Alvarez, O. et al. Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia. Pediatr. Blood Cancer 59, 668\u2013674 (2012).","journal-title":"Pediatr. Blood Cancer"},{"key":"BFnrneph20158_CR84","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.23365","volume":"88","author":"B Aygun","year":"2013","unstructured":"Aygun, B. et al. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Am. J. Hematol. 88, 116\u2013119 (2013).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR85","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/039139889001300604","volume":"13","author":"AH Sklar","year":"1990","unstructured":"Sklar, A. H., Perez, J. C., Harp, R. J. & Caruana, R. J. Acute renal failure in sickle cell anemia. Int. J. Artif. Organs 13, 347\u2013351 (1990).","journal-title":"Int. J. Artif. Organs"},{"key":"BFnrneph20158_CR86","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/ndt\/gfq083","volume":"25","author":"V Audard","year":"2010","unstructured":"Audard, V. et al. Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension. Nephrol. Dial. Transplant. 25, 2524\u20132529 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph20158_CR87","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/CCM.0000000000000316","volume":"42","author":"J Cecchini","year":"2014","unstructured":"Cecchini, J. et al. Outcomes of adult patients with sickle cell disease admitted to the ICU: a case series. Crit. Care Med. 42, 1629\u20131639 (2014).","journal-title":"Crit. Care Med."},{"key":"BFnrneph20158_CR88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0002-9343(94)90136-8","volume":"96","author":"KL Hassell","year":"1994","unstructured":"Hassell, K. L., Eckman, J. R. & Lane, P. A. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am. J. Med. 96, 155\u2013162 (1994).","journal-title":"Am. J. Med."},{"key":"BFnrneph20158_CR89","first-page":"153","volume":"23","author":"A Aderibigbe","year":"1994","unstructured":"Aderibigbe, A., Arije, A. & Akinkugbe, O. O. Glomerular function in sickle cell disease patients during crisis. Afr. J. Med. Med. Sci. 23, 153\u2013160 (1994).","journal-title":"Afr. J. Med. Med. Sci."},{"key":"BFnrneph20158_CR90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1750-1172-9-67","volume":"9","author":"V Audard","year":"2014","unstructured":"Audard, V. et al. First evidence of subclinical renal tubular injury during sickle-cell crisis. Orphanet J. Rare Dis. 9, 67 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"BFnrneph20158_CR91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","volume":"20","author":"KA Nath","year":"1992","unstructured":"Nath, K. A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am. J. Kidney Dis. 20, 1\u201317 (1992).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph20158_CR92","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI72267","volume":"124","author":"JS Duffield","year":"2014","unstructured":"Duffield, J. S. Cellular and molecular mechanisms in kidney fibrosis. J. Clin. Invest. 124, 2299\u20132306 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph20158_CR93","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1523-1755.2005.67097.x","volume":"67","author":"W Kriz","year":"2005","unstructured":"Kriz, W. & LeHir, M. Pathways to nephron loss starting from glomerular diseases\u2013insights from animal models. Kidney Int. 67, 404\u2013419 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR94","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ackd.2011.06.001","volume":"18","author":"P Garg","year":"2011","unstructured":"Garg, P. & Rabelink, T. Glomerular proteinuria: a complex interplay between unique players. Adv. Chronic Kidney Dis. 18, 233\u2013242 (2011).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrneph20158_CR95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/mic.11.2.129.151","volume":"11","author":"RP Hebbel","year":"2004","unstructured":"Hebbel, R. P., Osarogiagbon, R. & Kaul, D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 11, 129\u2013151 (2004).","journal-title":"Microcirculation"},{"key":"BFnrneph20158_CR96","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","volume":"84","author":"GJ Kato","year":"2009","unstructured":"Kato, G. J., Hebbel, R. P., Steinberg, M. H. & Gladwin, M. T. Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am. J. Hematol. 84, 618\u2013625 (2009).","journal-title":"Am. J. Hematol."},{"key":"BFnrneph20158_CR97","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MNH.0b013e32835b4e6e","volume":"22","author":"CM Peppiatt-Wildman","year":"2013","unstructured":"Peppiatt-Wildman, C. M. The evolving role of renal pericytes. Curr. Opin. Nephrol. Hypertens. 22, 10\u201316 (2013).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph20158_CR98","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jmri.21490","volume":"28","author":"A Schein","year":"2008","unstructured":"Schein, A., Enriquez, C., Coates, T. D. & Wood, J. C. Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis. J. Magn. Reson. Imaging 28, 698\u2013704 (2008).","journal-title":"J. Magn. Reson. Imaging"},{"key":"BFnrneph20158_CR99","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2141.2012.09093.x","volume":"157","author":"N Vasavda","year":"2012","unstructured":"Vasavda, N. et al. Renal iron load in sickle cell disease is influenced by severity of haemolysis. Br. J. Haematol. 157, 599\u2013605 (2012).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph20158_CR100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjh.12690","volume":"164","author":"SL Saraf","year":"2014","unstructured":"Saraf, S. L. et al. Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br. J. Haematol. 164, 729\u2013739 (2014).","journal-title":"Br. J. Haematol."},{"key":"BFnrneph20158_CR101","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1046\/j.1523-1755.2000.00101.x","volume":"57","author":"KA Nath","year":"2000","unstructured":"Nath, K. A., Croatt, A. J., Haggard, J. J. & Grande, J. P. Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int. 57, 2423\u20132433 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR102","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1523-1755.2001.00471.x","volume":"59","author":"KA Nath","year":"2001","unstructured":"Nath, K. A. et al. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int. 59, 106\u2013117 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR103","doi-asserted-by":"crossref","first-page":"F317","DOI":"10.1152\/ajprenal.00606.2012","volume":"304","author":"KA Nath","year":"2013","unstructured":"Nath, K. A. et al. Age sensitizes the kidney to heme protein-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 304, F317\u2013F325 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph20158_CR104","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","volume":"123","author":"JD Belcher","year":"2014","unstructured":"Belcher, J. D. et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 123, 377\u2013390 (2014).","journal-title":"Blood"},{"key":"BFnrneph20158_CR105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1681\/ASN.2006080894","volume":"18","author":"MJ Tracz","year":"2007","unstructured":"Tracz, M. J., Alam, J. & Nath, K. A. Physiology and pathophysiology of heme: implications for kidney disease. J. Am. Soc. Nephrol. 18, 414\u2013420 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR106","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.atherosclerosis.2012.07.043","volume":"224","author":"JA Moraes","year":"2012","unstructured":"Moraes, J. A. et al. Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system. Atherosclerosis 224, 394\u2013400 (2012).","journal-title":"Atherosclerosis"},{"key":"BFnrneph20158_CR107","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla, L. S., Eggers, P. W., Star, R. A. & Kimmel, P. L. Acute kidney injury and chronic kidney disease as interconnected syndromes. N. Engl. J. Med. 371, 58\u201366 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph20158_CR108","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0002-9440(10)62318-8","volume":"166","author":"KA Nath","year":"2005","unstructured":"Nath, K. A. et al. Transgenic sickle mice are markedly sensitive to renal ischemia\u2013reperfusion injury. Am. J. Pathol. 166, 963\u2013972 (2005).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph20158_CR109","doi-asserted-by":"crossref","first-page":"F892","DOI":"10.1152\/ajprenal.00631.2009","volume":"298","author":"JP Juncos","year":"2010","unstructured":"Juncos, J. P. et al. Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease. Am. J. Physiol. Renal Physiol. 298, F892\u2013F899 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph20158_CR110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1523-1755.2000.00143.x","volume":"58","author":"N Bank","year":"2000","unstructured":"Bank, N. et al. Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int. 58, 82\u201389 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR111","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2010.124","volume":"6","author":"I Mimura","year":"2010","unstructured":"Mimura, I. & Nangaku, M. The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat. Rev. Nephrol. 6, 667\u2013678 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph20158_CR112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e32835f55f9","volume":"20","author":"K Sun","year":"2013","unstructured":"Sun, K. & Xia, Y. New insights into sickle cell disease: a disease of hypoxia. Curr. Opin. Hematol. 20, 215\u2013221 (2013).","journal-title":"Curr. Opin. Hematol."},{"key":"BFnrneph20158_CR113","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ki.2008.350","volume":"74","author":"LG Fine","year":"2008","unstructured":"Fine, L. G. & Norman, J. T. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int. 74, 867\u2013872 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR114","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrneph.2011.219","volume":"8","author":"DA Long","year":"2012","unstructured":"Long, D. A., Norman, J. T. & Fine, L. G. Restoring the renal microvasculature to treat chronic kidney disease. Nat. Rev. Nephrol. 8, 244\u2013250 (2012).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph20158_CR115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ki.2012.20","volume":"82","author":"I Grgic","year":"2012","unstructured":"Grgic, I. et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 82, 172\u2013183 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR116","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1172\/JCI33308","volume":"118","author":"N Sabaa","year":"2008","unstructured":"Sabaa, N. et al. Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. J. Clin. Invest. 118, 1924\u20131933 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph20158_CR117","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2012-02-413138","volume":"120","author":"SM Camus","year":"2012","unstructured":"Camus, S. M. et al. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease. Blood 120, 5050\u20135058 (2012).","journal-title":"Blood"},{"key":"BFnrneph20158_CR118","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nm.2280","volume":"17","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. Detrimental effects of adenosine signaling in sickle cell disease. Nat. Med. 17, 79\u201386 (2011).","journal-title":"Nat. Med."},{"key":"BFnrneph20158_CR119","first-page":"S109","volume":"38","author":"KA Nath","year":"1992","unstructured":"Nath, K. A., Salahudeen, A. K., Clark, E. C., Hostetter, M. K. & Hostetter, T. H. Role of cellular metabolites in progressive renal injury. Kidney Int. Suppl. 38, S109\u2013S113 (1992).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph20158_CR120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(75)90604-X","volume":"58","author":"J Strauss","year":"1975","unstructured":"Strauss, J., Pardo, V., Koss, M. N., Griswold, W. & McIntosh, R. M. Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. I. Studies on nature of glomerular-bound antibody and antigen identification in a patient with sickle cell disease and immune deposit glomerulonephritis. Am. J. Med. 58, 382\u2013387 (1975).","journal-title":"Am. J. Med."},{"key":"BFnrneph20158_CR121","first-page":"85","volume":"21","author":"RC McCoy","year":"1969","unstructured":"McCoy, R. C. Ultrastructural alterations in the kidney of patients with sickle cell disease and the nephrotic syndrome. Lab. Invest. 21, 85\u201395 (1969).","journal-title":"Lab. Invest."},{"key":"BFnrneph20158_CR122","first-page":"109","volume":"5","author":"ML Weber","year":"2012","unstructured":"Weber, M. L. et al. Morphine promotes renal pathology in sickle mice. Int. J. Nephrol. Renovasc. Dis. 5, 109\u2013118 (2012).","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"BFnrneph20158_CR123","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI103360","volume":"35","author":"HA Itano","year":"1956","unstructured":"Itano, H. A., Keitel, H. G. & Thompson, D. Hyposthenuria in sickle cell anemia: a reversible renal defect. J. Clin. Invest. 35, 998\u20131007 (1956).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph20158_CR124","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00304.2002","volume":"284","author":"TL Pallone","year":"2003","unstructured":"Pallone, T. L., Zhang, Z. & Rhinehart, K. Physiology of the renal medullary microcirculation. Am. J. Physiol. Renal Physiol. 284, F253\u2013F266 (2003).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph20158_CR125","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.urology.2007.06.1124","volume":"70","author":"AA Hakimi","year":"2007","unstructured":"Hakimi, A. A. et al. Renal medullary carcinoma: the Bronx experience. Urology 70, 878\u2013882 (2007).","journal-title":"Urology"},{"key":"BFnrneph20158_CR126","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.humpath.2011.02.026","volume":"42","author":"Z Gatalica","year":"2011","unstructured":"Gatalica, Z. et al. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes. Hum. Pathol. 42, 1979\u20131988 (2011).","journal-title":"Hum. Pathol."},{"key":"BFnrneph20158_CR127","first-page":"270","volume":"14","author":"A Shetty","year":"2014","unstructured":"Shetty, A. & Matrana, M. R. Renal medullary carcinoma: a case report and brief review of the literature. Ochsner J. 14, 270\u2013275 (2014).","journal-title":"Ochsner J."},{"key":"BFnrneph20158_CR128","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2215\/CJN.09790913","volume":"9","author":"S Maurel","year":"2014","unstructured":"Maurel, S. et al. Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease. Clin. J. Am. Soc. Nephrol. 9, 648\u2013653 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-90-3-310","volume":"90","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo, R. A., Taufield, P. A., Black, H., McPhedran, P. & Cooke, C. R. Impaired renal tubular potassium secretion in sickle cell disease. Ann. Intern. Med. 90, 310\u2013316 (1979).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph20158_CR130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-9343(82)90809-9","volume":"72","author":"D Batlle","year":"1982","unstructured":"Batlle, D., Itsarayoungyuen, K., Arruda, J. A. & Kurtzman, N. A. Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. Am. J. Med. 72, 188\u2013192 (1982).","journal-title":"Am. J. Med."},{"key":"BFnrneph20158_CR131","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2008.12.020","volume":"122","author":"G Tsaras","year":"2009","unstructured":"Tsaras, G., Owusu-Ansah, A., Boateng, F. O. & Amoateng-Adjepong, Y. Complications associated with sickle cell trait: a brief narrative review. Am. J. Med. 122, 507\u2013512 (2009).","journal-title":"Am. J. Med."},{"key":"BFnrneph20158_CR132","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/asheducation-2010.1.418","volume":"2010","author":"NS Key","year":"2010","unstructured":"Key, N. S. & Derebail, V. K. Sickle-cell trait: novel clinical significance. Hematology Am. Soc. Hematol. Educ. Program 2010, 418\u2013422 (2010).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"BFnrneph20158_CR133","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/ndt\/gfq186","volume":"25","author":"C Shaw","year":"2010","unstructured":"Shaw, C. & Sharpe, C. C. Could sickle cell trait be a predisposing risk factor for CKD? Nephrol. Dial. Transplant. 25, 2403\u20132405 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph20158_CR134","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.2009070705","volume":"21","author":"VK Derebail","year":"2010","unstructured":"Derebail, V. K. et al. High prevalence of sickle cell trait in African Americans with ESRD. J. Am. Soc. Nephrol. 21, 413\u2013417 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR135","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/ki.2011.286","volume":"80","author":"PJ Hicks","year":"2011","unstructured":"Hicks, P. J. et al. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Kidney Int. 80, 1339\u20131343 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph20158_CR136","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejim.2004.06.003","volume":"15","author":"AA Ajayi","year":"2004","unstructured":"Ajayi, A. A. & Kolawole, B. A. Sickle cell trait and gender influence type 2 diabetic complications in African patients. Eur. J. Intern. Med. 15, 312\u2013315 (2004).","journal-title":"Eur. J. Intern. Med."},{"key":"BFnrneph20158_CR137","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.08841209","volume":"5","author":"AJ Bleyer","year":"2010","unstructured":"Bleyer, A. J. et al. Sickle cell trait and development of microvascular complications in diabetes mellitus. Clin. J. Am. Soc. Nephrol. 5, 1015\u20131020 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR138","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","volume":"312","author":"RP Naik","year":"2014","unstructured":"Naik, R. P. et al. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. JAMA 312, 2115\u20132125 (2014).","journal-title":"JAMA"},{"key":"BFnrneph20158_CR139","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1681\/ASN.V491670","volume":"4","author":"J Yium","year":"1994","unstructured":"Yium, J., Gabow, P., Johnson, A., Kimberling, W. & Martinez-Maldonado, M. Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin. J. Am. Soc. Nephrol. 4, 1670\u20131674 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph20158_CR140","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1056\/NEJMcibr1105118","volume":"364","author":"PJ Rosenthal","year":"2011","unstructured":"Rosenthal, P. J. Lessons from sickle cell disease in the treatment and control of malaria. N. Engl. J. Med. 364, 2549\u20132551 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph20158_CR141","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cell.2011.03.049","volume":"145","author":"A Ferreira","year":"2011","unstructured":"Ferreira, A. et al. Sickle hemoglobin confers tolerance to Plasmodium infection. Cell 145, 398\u2013409 (2011).","journal-title":"Cell"},{"key":"BFnrneph20158_CR142","volume-title":"55th ASH Annual Meeting and Exposition","author":"S Roy","year":"2013","unstructured":"Roy, S. et al. Increased oxidative stress in sickle cell disease activates the renin-angiotensin-TGF-\u03b2 pathway to mediate sickle nephropathy. 55vth ASH Annual Meeting and Exposition https:\/\/ash.confex.com\/ash\/2013\/webprogram\/Paper64925.html (2013)."},{"key":"BFnrneph20158_CR143","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1871529X10909040271","volume":"9","author":"RP Hebbel","year":"2009","unstructured":"Hebbel, R. P., Vercellotti, G. & Nath, K. A. A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis. Cardiovasc. Hematol. Disord. Drug Targets. 9, 271\u2013292 (2009).","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:47:36Z","timestamp":1684457256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2015.8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,10]]},"references-count":143,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFnrneph20158"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2015.8","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,10]]},"assertion":[{"value":"10 February 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}